S22-038 Rejuvenating the Immune System through Depletion of Myeloid-Biased Hematopoietic Stem Cells There are two subsets of Hematopoietic stem cells (HSC); one subset that provides balanced production of myeloid and lymphoid cells, and another that is biased toward production of the myeloid lineage. Jason Ross Lara Myers Joseph Noh Kim Hasenkrug Irving Weissman
S21-223 Blocking and Reversing Extracellular Vesicle-Driven Transcriptomic Transformation with Annexin V Treatment Stanford researchers led by Dr. Francis Blankenberg Derek Holman
S20-364 New Immunotherapeutic Target for the Treatment of Lung Cancer and Fibrotic Lung Diseases Stanford scientists have discovered a new immunotherapeutic target for treating lung cancer and fibrotic lung disease. Gerlinde Wernig Tristan Lerbs Lu Cui Qiwen Deng Cristabelle De Souza